echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Luoxin Pharmaceutical: Lansoprazole for injection passed the consistency evaluation of generic drugs

    Luoxin Pharmaceutical: Lansoprazole for injection passed the consistency evaluation of generic drugs

    • Last Update: 2021-08-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On June 22, Luoxin Pharmaceutical announced that lansoprazole for injection passed the quality and efficacy consistency evaluation of generic drugs


    Lansoprazole for injection is suitable for gastric, duodenal ulcer, acute stress ulcer, and acute gastric mucosal injury with bleeding that is not suitable for oral therapy


    According to IQVIA data, the global sales of lansoprazole for injection in 2020 will be 210 million U.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.